Clinical Researchers Present Initial Results from Key Clinical Studies Designed to Evaluate the Performance of Saphyr® Against Traditional Cytogenetics Methods at the European Human Genetics Conference

Home/Client News/Clinical Researchers Present Initial Results from Key Clinical Studies Designed to Evaluate the Performance of Saphyr® Against Traditional Cytogenetics Methods at the European Human Genetics Conference

Clinical Researchers Present Initial Results from Key Clinical Studies Designed to Evaluate the Performance of Saphyr® Against Traditional Cytogenetics Methods at the European Human Genetics Conference

SAN DIEGO, June 14, 2019 (GLOBE NEWSWIRE) — Bionano Genomics, Inc. (BNGO), a life sciences instrumentation company that develops and markets Saphyr®, a platform for ultra-sensitive and ultra-specific structural variation detection in genome analysis announces presentations of initial results of two key clinical studies at the European Human Genetics Conference, the annual conference of the European Society of Human Genetics (ESHG), taking place June 15 to 18 in Gothenburg, Sweden.

By | 2019-06-14T14:15:35+00:00 June 14th, 2019|Client News|Comments Off on Clinical Researchers Present Initial Results from Key Clinical Studies Designed to Evaluate the Performance of Saphyr® Against Traditional Cytogenetics Methods at the European Human Genetics Conference